unknown
Stage
About
Inaedis develops scalable biopharmaceutical technology that converts liquid biologics into room-temperature-stable powder and suspension formulations, enabling flexible administration routes such as inhaled, intranasal, and subcutaneous delivery.
Explore Inaedis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.